bioRxiv preprint doi: https://doi.org/10.1101/348268; this version posted June 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Metal-independent ribonucleotide reduction powered by a DOPA radical in Mycoplasma pathogens Vivek Srinivas1†, Hugo Lebrette1†, Daniel Lundin1, Yuri Kutin2, Margareta Sahlin1, Michael Lerche1, Jürgen Eirich3, Rui M. M. Branca3, Nicholas Cox4, Britt-Marie Sjöberg1 and Martin Högbom1* 1Department of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, SE-10691 Stockholm, Sweden. 2Max Planck Institute for Chemical Energy Conversion, Stiftstraße 34-36, D-45470, Mülheim an der Ruhr, Germany. 3Cancer Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Box 1031, SE-171 21 Solna, Sweden 4Research School of Chemistry, Australian National University, Canberra, Australian Capital Territory 2601, Australia. * To whom correspondence should be addressed. E-mail:
[email protected] † Equal contribution 1 bioRxiv preprint doi: https://doi.org/10.1101/348268; this version posted June 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Ribonucleotide reductase (RNR) catalyzes the only known de-novo pathway for production of all four deoxyribonucleotides required for DNA synthesis. In aerobic RNRs, a di-nuclear metal site is viewed as an absolute requirement for generating and stabilizing an essential catalytic radical.